Under the synergistic effect of radiotherapy, anti‐CPG3‐NK92 cells engineered with CXCR2 displayed potent cytotoxicity against hepatocellular carcinoma (HCC), though the antitumor effect varied with different radiation doses [35]. The gene discussed is CXCR2; the disease is hepatocellular carcinoma.